Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CTSB | P07858 | 2/20 | 0.34 |
| ▸ | PIN1 | Q13526 | 8/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CASP6 | P55212 | 1/20 | 0.32 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3667637 | 0.96 | PIN1 (0.34) | ALDH1A1GAAMAPTCTSBPIN1 | |
| SCHEMBL10024797 | 0.87 | ALDH1A1 (0.35) | ALDH1A1MEN1GAAKMT2AMAPT | |
| SCHEMBL3672527 | 0.86 | ALDH1A1 (0.38) | ALDH1A1MEN1GAAKMT2AMAPT | |
| SCHEMBL30823384 | 0.82 | PIN1 (0.37) | ALDH1A1MEN1GAAKMT2APIN1 | |
| SCHEMBL4085806 | 0.82 | KMT2A (0.38) | ALDH1A1MEN1GAAKMT2AMAPT | |
| SCHEMBL4083814 | 0.82 | HSD11B1 (0.34) | ALDH1A1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL1288258 | 0.82 | PIN1 (0.35) | ALDH1A1MEN1GAAKMT2AMAPT | |
| SCHEMBL1288267 | 0.82 | PIN1 (0.35) | ALDH1A1MEN1GAAKMT2AMAPT | |
| SCHEMBL10450445 | 0.82 | PIN1 (0.35) | ALDH1A1MEN1GAAKMT2AMAPT | |
| SCHEMBL736395 | 0.81 | PIN1 (0.36) | PIN1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7517873-B2 | Substituted pyrimidodiazepines | HOFFMAN-LA ROCHE INC. (US) | 2009-04-14 | — | — | US | disclosed |
| US-20080234255-A1 | SUBSTITUTED PYRIMIDODIAZEPINES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234255-A1 | SUBSTITUTED PYRIMIDODIAZEPINES | PLK1, CCNI, CDK1 | ALDH1A1 1365/4885MEN1 1136/4885GAA 3095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.